RedHill Biopharma | RDHL - Current Liabilities

Stock Price
0.87
Daily Change
-0.01 -1.14%
Monthly
-14.71%
Yearly
-66.02%
Q1 Forecast
0.84

RedHill Biopharma reported $22.29M in Current Liabilities for its fiscal quarter ending in June of 2025.





Current Liabilities Change Date
Cara Therapeutics USD 10.68M 9.48M Jun/2025
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 20.28M 300K Sep/2025
Cronos Group USD 48.19M 7.12M Dec/2025
RedHill Biopharma USD 22.29M 64K Jun/2025